PURPOSE: To determine the prevalence of serum antiretinal antibodies (ARAs) among patients with uveitis and establish their clinical relevance. METHODS: This prospective study assessed the presence of ARAs by indirect immunofluorescence (IIF) using primate retina in 126 patients with uveitis and 60 healthy controls. Clinical data of uveitis patients were collected from medical charts and included the classification of uveitis, cause of uveitis or its association with systemic disease, stage and activity of uveitis and specific retinal features. Correlations between the presence of specific ARAs and various clinical characteristics were analysed. RESULTS: The presence of ARAs was observed in 49 of 104 (47%) of patients with uveitis and in 10 of 59 (17%) of healthy controls (p < 0.001). Staining of the nuclear layers or the photoreceptors were both more often observed in patients with uveitis compared to healthy controls (p = 0.002 and p = 0.018, respectively). No specific associations were found between the presence of serum ARAs and various clinical characteristics. CONCLUSION: Serum ARAs were more frequent in patients with uveitis compared to healthy controls, but their clinical role remains elusive. The assessment of intraocular production of specific ARAs may provide further insight into the role of ocular autoantibodies in diverse uveitis entities.
PURPOSE: To determine the prevalence of serum antiretinal antibodies (ARAs) among patients with uveitis and establish their clinical relevance. METHODS: This prospective study assessed the presence of ARAs by indirect immunofluorescence (IIF) using primate retina in 126 patients with uveitis and 60 healthy controls. Clinical data of uveitispatients were collected from medical charts and included the classification of uveitis, cause of uveitis or its association with systemic disease, stage and activity of uveitis and specific retinal features. Correlations between the presence of specific ARAs and various clinical characteristics were analysed. RESULTS: The presence of ARAs was observed in 49 of 104 (47%) of patients with uveitis and in 10 of 59 (17%) of healthy controls (p < 0.001). Staining of the nuclear layers or the photoreceptors were both more often observed in patients with uveitis compared to healthy controls (p = 0.002 and p = 0.018, respectively). No specific associations were found between the presence of serum ARAs and various clinical characteristics. CONCLUSION: Serum ARAs were more frequent in patients with uveitis compared to healthy controls, but their clinical role remains elusive. The assessment of intraocular production of specific ARAs may provide further insight into the role of ocular autoantibodies in diverse uveitis entities.
Authors: Basheer Khassawneh; Chengsong Zhu; Briana Barkes; Brian Vestal; Sarah Shrock; May Gillespie; Karin Pacheco; Kevin D Deane; Lisa A Maier; Quan-Zhen Li; Nabeel Hamzeh Journal: PLoS One Date: 2022-10-20 Impact factor: 3.752
Authors: Monica Goldberg-Murow; Carlos Cedillo-Peláez; Luz Elena Concha-Del-Río; Rashel Cheja-Kalb; María José Salgar-Henao; Eduardo Orozco-Velasco; Héctor Luna-Pastén; Fernando Gómez-Chávez; Antonio Ibarra; Dolores Correa Journal: Front Immunol Date: 2021-05-12 Impact factor: 7.561
Authors: Josianne C Ten Berge; Joost van Rosmalen; Jacolien Vermeer; Cecilia Hellström; Cecilia Lindskog; Peter Nilsson; Ulrika Qundos; Aniki Rothova; Marco W J Schreurs Journal: PLoS One Date: 2016-12-08 Impact factor: 3.240
Authors: Hashem Ghoraba; Christopher Or; Irmak Karaca; Kapil Mishra; Amir Akhavanrezayat; Sungwho Park; Ngoc Than; Loh-Shan Leung; Steven Sanislo; Quan Dong Nguyen Journal: Am J Ophthalmol Case Rep Date: 2022-03-01
Authors: Carlos Cifuentes-González; Pilar Uribe-Reina; Juliana Reyes-Guanes; Juliana Muñoz-Ortiz; Paula Tatiana Muñoz-Vargas; William Rojas-Carabali; Dora Victoria Nova-Florián; Ana Sofía De-Los-Ríos; Rubén Dario Mantilla-Hernández; Alejandra de-la-Torre Journal: Clin Ophthalmol Date: 2022-08-09
Authors: Saskia H M van Romunde; Daphne P C Vergouwen; Daniela Iacovello; Dave L Roelen; Robert M Verdijk; Josianne C E M Ten Berge; Grazia Pertile; Marco W J Schreurs; Jan C van Meurs Journal: J Ophthalmic Inflamm Infect Date: 2022-08-26